Home/Filings/4/0001104659-23-087443
4//SEC Filing

Poll Claire 4

Accession 0001104659-23-087443

CIK 0001657312other

Filed

Aug 2, 8:00 PM ET

Accepted

Aug 3, 8:30 PM ET

Size

8.0 KB

Accession

0001104659-23-087443

Insider Transaction Report

Form 4
Period: 2023-08-01
Poll Claire
General Counsel
Transactions
  • Sale

    Ordinary Shares

    2023-08-01$2.68/sh18,608$49,8511,968,783 total
  • Sale

    Ordinary Shares

    2023-08-02$2.59/sh12,944$33,5641,955,839 total
Holdings
  • Ordinary Shares

    (indirect: By Trust)
    774,256
Footnotes (5)
  • [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
  • [F2]The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on May 14, 2021 solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units.
  • [F3]The price reported represents the sale price of the ADSs divided by eight (8).
  • [F4]Consists of (i) 1,471,672 Ordinary Shares underlying RSUs (which are represented by 183,959 ADSs); (ii) 484,160 Ordinary Shares underlying 60,520 ADSs and (iii) 7 Ordinary Shares.
  • [F5]Held by a family trust of which (a) the Reporting Person and spouse are trustees and (b) the Reporting Person and members of her immediate family are the sole beneficiaries of the trust.

Issuer

Verona Pharma plc

CIK 0001657312

Entity typeother

Related Parties

1
  • filerCIK 0001836820

Filing Metadata

Form type
4
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 8:30 PM ET
Size
8.0 KB